Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting
mediaposted on 2020-08-28, 10:04 authored by Virginia Martín, Josep Vidal, Samuel J. P. Malkin, Nino Hallén, Barnaby Hunt
The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.